Related Experiment Videos
Urinary cytologic abnormalities in bone marrow transplant recipients of cyclosporin
F Stella1, R Troccoli, C Stella
1Institute of Human Anatomy, University of Rome, Italy.
Abstract:
The role of urinary cytology in the early diagnosis of cyclosporin nephrotoxicity was studied in 20 bone marrow transplant recipients. There was an evident cyclosporin cytopathy in 35% of bone marrow transplant recipients examined, consisting mainly of degenerative and necrotic abnormalities in cells of the proximal convoluted tubules seen in urinary samples. These findings regressed to normal after reduction of the cyclosporin dose. Urinary cytology proved to be a useful method for the early diagnosis of cyclosporin nephrotoxicity.
Insights
Urinary cytology effectively detects early cyclosporin nephrotoxicity in bone marrow transplant patients. This method identified cellular damage, which resolved upon reducing cyclosporin dosage, aiding early diagnosis.
Area of Science:
- Nephrology
- Oncology
- Transplantation
Background:
- Cyclosporin is a vital immunosuppressant in bone marrow transplantation.
- Nephrotoxicity is a significant complication of cyclosporin therapy.
- Early detection of cyclosporin nephrotoxicity is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the utility of urinary cytology for early diagnosis of cyclosporin-induced kidney damage.
- To identify specific urinary cellular abnormalities indicative of cyclosporin nephrotoxicity.
Main Methods:
- Study involved 20 bone marrow transplant recipients undergoing cyclosporin treatment.
- Urinary samples were analyzed using cytology to detect cellular abnormalities.
- Cyclosporin dosage was adjusted based on clinical and cytological findings.
Main Results:
- Cyclosporin cytopathy was observed in 35% of patients.
- Abnormalities included degenerative and necrotic changes in proximal convoluted tubule cells.
- These cytological findings normalized after a reduction in cyclosporin dosage.
Conclusions:
- Urinary cytology is a valuable, non-invasive tool for the early detection of cyclosporin nephrotoxicity.
- Monitoring urinary cytology can guide therapeutic adjustments in cyclosporin dosage.